These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer. Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320 [TBL] [Abstract][Full Text] [Related]
11. Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. Schwartz V; Krüttgen A; Weis J; Weber C; Ostendorf T; Lue H; Bernhagen J Eur J Cell Biol; 2012; 91(6-7):435-49. PubMed ID: 22014447 [TBL] [Abstract][Full Text] [Related]
12. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells. DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658 [TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway. Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873 [TBL] [Abstract][Full Text] [Related]
15. CD74 expression and its therapeutic potential in thyroid carcinoma. Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560 [TBL] [Abstract][Full Text] [Related]
16. Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins. Meyer-Siegler KL; Xia SL; Vera PL Mediators Inflamm; 2009; 2009():535348. PubMed ID: 19325914 [TBL] [Abstract][Full Text] [Related]
17. Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs. Sinitski D; Gruner K; Brandhofer M; Kontos C; Winkler P; Reinstädler A; Bourilhon P; Xiao Z; Cool R; Kapurniotu A; Dekker FJ; Panstruga R; Bernhagen J J Biol Chem; 2020 Jan; 295(3):850-867. PubMed ID: 31811089 [TBL] [Abstract][Full Text] [Related]
18. Serum Levels of Migration Inhibitory Factor (MIF) and Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M Front Immunol; 2018; 9():246. PubMed ID: 29487601 [TBL] [Abstract][Full Text] [Related]
19. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis. Rijvers L; Melief MJ; van der Vuurst de Vries RM; Stéphant M; van Langelaar J; Wierenga-Wolf AF; Hogervorst JM; Geurts-Moespot AJ; Sweep FCGJ; Hintzen RQ; van Luijn MM Eur J Immunol; 2018 Nov; 48(11):1861-1871. PubMed ID: 30160778 [TBL] [Abstract][Full Text] [Related]
20. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer. Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]